Responses
Regular and Young Investigator Award Abstracts
Clinical Trial Completed
594 SQZ-PBMC-HPV-101: Increased overall survival in a subset of patients with recurrent, locally advanced, or metastatic HPV16+ tumors treated with cell-based vaccine, SQZ-PBMC-HPV
Compose a Response to This Article
Other responses
No responses have been published for this article.
